Today: 10 June 2026
Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds
10 June 2026
3 mins read

Snap Shares Drop Again With Tech Names Under Pressure

New York, June 10, 2026, 5:03 PM EDT

  • Snap Inc. shares traded at $5.38, off about 4% from Tuesday’s close of $5.59. That move keeps the stock lower for a third straight session.
  • The drop happened as U.S. tech stocks fell, sending the Nasdaq Composite down roughly 2%. Investors pointed to weaker chip names, fresh rate concerns and new worries over U.S.-Iran tensions.
  • Snap’s near-term focus is on turning better cash flow and cost cuts into enough of a cushion to balance out choppy ad growth, as CEO Evan Spiegel gets set for his June 16 AWE slot.

Snap Inc. shares dropped again Wednesday, adding stress to a turnaround built on stronger cash flow, lower costs and hopes for its Specs AR glasses. The stock traded at $5.38, down from Tuesday’s $5.59 close, swinging between $5.31 and $5.55. There’s no fresh earnings news driving the move. The slide is happening as traders gauge if Snap’s better numbers can matter right now in a market pulling back on risk.

Selling came after SNAP lost 1.06% on Tuesday, ending at $5.59 and extending its losing streak to three sessions, MarketWatch said. Shares are trading well under the 52-week high of $10.41. Snap is still seen as a shaky recovery bet, not a sure growth play.

Markets were under pressure. Reuters said U.S. indexes closed down more than 1% on Wednesday. The Nasdaq Composite lost about 1.97%. Tech stocks slipped and fresh tensions between the U.S. and Iran weighed on sentiment. When the market trades this way, smaller internet names that aren’t profitable tend to get hit harder.

No new announcement from Snap on Wednesday. The most recent update on Snap’s investor site was a June 3 credit-rating upgrade. Its June newsletter told investors to watch Spiegel’s June 16 keynote at Augmented World Expo, called “Making Computing More Human.” Snap Inc.

Snap shares are trading today on renewed confidence after the company’s first-quarter results showed clear improvements. Revenue climbed 12% year over year to $1.53 billion, while net loss came in at $89 million. Operating cash flow was $327 million, and free cash flow hit $286 million. Free cash flow is the cash left after capital expenses and is seen as an important sign for firms looking to fund growth without relying on outside money.

Snap CEO Evan Spiegel said the quarter marked a turning point for the company, with daily active users “returning to growth” and the business turning out “strong free cash flow.” Snap posted 483 million daily active users and 956 million monthly active users in Q1. Daily active users are people using the platform at least once a day. Snap Inc.

Snap is mixing things up, but ads are still in focus. In the Q1 investor letter, the company said advertising revenue grew just 3% from a year ago to $1.24 billion. Other Revenue shot up 87% to $285 million, helped by subscriptions and other products. That’s diversification, but the ad business is still front and center for investors.

Management flagged weakness with big North American advertisers in Q1, though small and mid-sized business trends picked up. Snap reported global impression volume up about 17%, but total eCPMs dropped around 12%. That’s putting pressure on near-term revenue as new ad surfaces ramp.

S&P Global Ratings lifted Snap’s issuer credit rating to BB- from B+ and set a positive outlook. The agency pointed to lower adjusted leverage, stronger free operating cash flow to debt, revenue gains and cost cuts. CFO Doug Hott said the move “reflects the progress we are making to strengthen Snap’s financial profile while continuing to invest in our long-term growth opportunities.” Snap Inc.

Snap is leaning on cost cuts. The company told investors it expects more than $500 million in annualized cost reductions in the second half of 2026. Snap is also forecasting $95 million to $130 million in pre-tax restructuring charges for Q2. For adjusted EBITDA—which strips out interest, taxes, depreciation, amortization and some other costs—Snap expects a range of $175 million to $200 million for Q2.

The risk is that the rebound takes more time than the market expects. Snap posted another net loss in Q1. Its ad business is still exposed to big-picture swings, and major North American advertisers aren’t back yet. Lower eCPMs might hold back revenue even if ad impressions rise. Snap also said it’s facing legal and regulatory issues in areas like age checks, privacy, ad standards and online safety, which could mean higher costs or hurt user growth.

Snap’s next shot is coming up fast. CEO Evan Spiegel is set to speak at AWE on June 16, putting the spotlight on Specs and its smart eyewear push. But the recent slide in Snap shares shows the market is looking beyond new products. Investors want to see Snap deliver real gains from engagement, subscriptions, and ad products that last.

Stock Market Today

  • Stock Market Expert Marta Norton On Balancing Geopolitics and Inflation
    June 10, 2026, 5:40 PM EDT. Stock market expert Marta Norton discusses strategies to balance the impact of geopolitical tensions and rising inflation on investments. She emphasizes the importance of diversification across sectors and regions to mitigate risks from international conflicts and economic pressures. Norton advises investors to focus on asset classes that historically perform well during inflationary periods, such as commodities and inflation-protected securities. She also highlights the need for vigilance in monitoring central bank policies, as they can influence market volatility. By combining geopolitical awareness with inflation hedging, investors can better navigate uncertain markets and protect portfolio value.

Latest articles

Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

10 June 2026
Outlook Therapeutics soared 26% to $0.89 on heavy volume as investors zeroed in on the FDA’s 60-day review window for Lytenava after a successful appeal, but risks remain with the stock still under $1, looming Nasdaq compliance deadlines, and warnings of possible dilution and going-concern doubts if FDA approval or favorable labeling isn’t secured soon.
Freshworks Stock Steady at $9.39 Ahead of AI Test

Freshworks Stock Steady at $9.39 Ahead of AI Test

10 June 2026
Freshworks traded flat near $9.39 on volume more than double average as investors weighed its AI-driven restructuring and Freshservice focus; with Q2 restructuring costs looming, the stock faces a key test to prove AI shifts can boost margins without hurting growth, while net dollar retention dipped to 106% and large-customer ARR rose 29%.
Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up
Previous Story

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Go toTop